TET2 and myeloproliferative disorder: In this study, we analyzed the risk factors for thrombotic events in 125 patients with PV and ET, applied next-generation sequencing technology to detect 31 MPN-related gene mutations, and observed that the TET2 mutation is an independent risk factor for thrombosis in ET patients, but no such association was observed in PV patients.